Plato Investment Management’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.73M Buy
8,185
+184
+2% +$39.6K 0.12% 186
2025
Q4
$1.65M Sell
8,001
-436
-5% -$82.1K 0.11% 192
2025
Q3
$1.31M Hold
8,437
0.09% 229
2025
Q2
$1.41M Buy
8,437
+3,197
+61% +$474K 0.11% 201
2025
Q1
$730K Sell
5,240
-83
-2% -$10.6K 0.06% 283
2024
Q4
$632K Buy
5,323
+584
+12% +$68.2K 0.05% 316
2024
Q3
$523K Hold
4,739
0.04% 313
2024
Q2
$466K Hold
4,739
0.04% 282
2024
Q1
$530K Buy
4,739
+4,656
+5,610% +$502K 0.05% 262
2023
Q4
$8.37K Buy
+83
New +$8.23K 0.01% 369

Other funds holding CAH

Plato Investment Management's CAH Position: Q1 2026 in Review

Plato Investment Management increased its Cardinal Health (CAH) stake by 2.3% in Q1 2026, buying an estimated $39.6K and bringing the position to 8,185 shares worth $1.73M. The position accounts for 0.12% of the portfolio, ranked #186.

Plato Investment Management first reported a position in CAH in Q4 2023 and has held it in 10 quarters since. 1,423 funds tracked by Wall St. Rank hold CAH as of Q1 2026.

  • Plato Investment Management held 8,185 shares of Cardinal Health worth $1.73M as of Q1 2026.
  • Plato Investment Management bought 184 Cardinal Health shares in Q1 2026, an estimated $39.6K.
  • Cardinal Health made up 0.12% of Plato Investment Management's portfolio in Q1 2026, its #186 holding.
  • Plato Investment Management first reported a position in Cardinal Health in Q4 2023 and has held it in 10 quarters since.
  • 1,423 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.

Based on Plato Investment Management's 13F filing for Q1 2026, filed 5 May 2026.